The risk or severity of heart failure can be increased when Pregabalin is combined with Saxagliptin. The therapeutic efficacy of Brotizolam can be increased when used in combination with Pregabalin. The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Thymol is combined with Pregabalin. The serum concentration of Pregabalin can be decreased when it is combined with Orlistat. The metabolism of Pregabalin can be increased when combined with Nafcillin. The risk or severity of adverse effects can be increased when Pregabalin is combined with Fluvastatin. The therapeutic efficacy of Eszopiclone can be increased when used in combination with Pregabalin. Labetalol may increase the hypotensive activities of Pregabalin. The therapeutic efficacy of Isoflurane can be increased when used in combination with Pregabalin. The therapeutic efficacy of Bupivacaine can be increased when used in combination with Pregabalin. Pregabalin may increase the hypotensive activities of Nitroprusside. The therapeutic efficacy of clomethiazole can be decreased when used in combination with Pregabalin. The therapeutic efficacy of Cocaine can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Salicylic acid is combined with Pregabalin. The risk or severity of adverse effects can be increased when Sirolimus is combined with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with Liraglutide. The risk or severity of heart failure can be increased when Pregabalin is combined with Balaglitazone. The therapeutic efficacy of Nitrous oxide can be increased when used in combination with Pregabalin. The therapeutic efficacy of Asenapine can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Pregabalin is combined with Escitalopram. The therapeutic efficacy of Zopiclone can be increased when used in combination with Pregabalin. The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Pregabalin. The therapeutic efficacy of Etizolam can be increased when used in combination with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Aspart. The risk or severity of adverse effects can be increased when Pregabalin is combined with Lovastatin. The therapeutic efficacy of Mesoridazine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Clorazepate can be decreased when used in combination with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with Phenformin. Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. The risk or severity of heart failure can be increased when Pregabalin is combined with Ciglitazone. The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone. The risk or severity of adverse effects can be increased when Voriconazole is combined with Pregabalin. The therapeutic efficacy of Alfentanil can be increased when used in combination with Pregabalin. The therapeutic efficacy of Pregabalin can be decreased when used in combination with Calcium Acetate. The risk or severity of adverse effects can be increased when Anidulafungin is combined with Pregabalin. The therapeutic efficacy of Proparacaine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Pipamperone can be increased when used in combination with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Pork. The therapeutic efficacy of Flunarizine can be decreased when used in combination with Pregabalin. Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pregabalin. The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Pregabalin. The serum concentration of Pregabalin can be decreased when it is combined with Rifabutin. The therapeutic efficacy of Methadone can be increased when used in combination with Pregabalin. The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Pregabalin is combined with Levomilnacipran. The therapeutic efficacy of 7-Nitroindazole can be decreased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Pregabalin is combined with Atorvastatin. The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Mevastatin is combined with Pregabalin. The therapeutic efficacy of Normethadone can be increased when used in combination with Pregabalin. The therapeutic efficacy of Triprolidine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Estazolam can be decreased when used in combination with Pregabalin. The therapeutic efficacy of Desipramine can be increased when used in combination with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with 2,4-thiazolidinedione. Minocycline may increase the central nervous system depressant (CNS depressant) activities of Pregabalin. The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with Tolbutamide. The therapeutic efficacy of Perphenazine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Guanfacine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Pregabalin. The therapeutic efficacy of Fospropofol can be increased when used in combination with Pregabalin. The serum concentration of Pregabalin can be decreased when it is combined with Rifampicin. The risk or severity of adverse effects can be increased when Nystatin is combined with Pregabalin. The risk or severity of adverse effects can be increased when Cerulenin is combined with Pregabalin. The therapeutic efficacy of Deramciclane can be decreased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Quinapril is combined with Pregabalin. The therapeutic efficacy of Melperone can be increased when used in combination with Pregabalin. The therapeutic efficacy of Tetrodotoxin can be increased when used in combination with Pregabalin. The therapeutic efficacy of Pipotiazine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Canertinib can be increased when used in combination with Pregabalin. The therapeutic efficacy of Brompheniramine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Etifoxine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Glutethimide can be increased when used in combination with Pregabalin. The therapeutic efficacy of Lurasidone can be increased when used in combination with Pregabalin. The therapeutic efficacy of Etomidate can be increased when used in combination with Pregabalin. The therapeutic efficacy of Paramethadione can be decreased when used in combination with Pregabalin. The therapeutic efficacy of Valpromide can be decreased when used in combination with Pregabalin. The therapeutic efficacy of Prazepam can be increased when used in combination with Pregabalin. The therapeutic efficacy of Methapyrilene can be increased when used in combination with Pregabalin. The therapeutic efficacy of Bromperidol can be increased when used in combination with Pregabalin. The therapeutic efficacy of Baclofen can be increased when used in combination with Pregabalin. The therapeutic efficacy of Pizotifen can be increased when used in combination with Pregabalin. The therapeutic efficacy of Chlorprothixene can be increased when used in combination with Pregabalin. The therapeutic efficacy of Entacapone can be increased when used in combination with Pregabalin. The therapeutic efficacy of Nalbuphine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Fentanyl can be increased when used in combination with Pregabalin. The therapeutic efficacy of Chlorpromazine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Carbinoxamine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Aceprometazine can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Capric acid is combined with Pregabalin. The risk or severity of adverse effects can be increased when Rescinnamine is combined with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with Insulin Detemir. The risk or severity of heart failure can be increased when Pregabalin is combined with Acetohexamide. The risk or severity of adverse effects can be increased when Terconazole is combined with Pregabalin. The metabolism of Pregabalin can be decreased when combined with Clarithromycin. Indoramin may increase the hypotensive activities of Pregabalin. The therapeutic efficacy of Scopolamine can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Micafungin is combined with Pregabalin. The therapeutic efficacy of Fexofenadine can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Pregabalin is combined with Magnesium Hydroxide. The therapeutic efficacy of Levorphanol can be increased when used in combination with Pregabalin. The therapeutic efficacy of Desloratadine can be increased when used in combination with Pregabalin. Dapoxetine may increase the orthostatic hypotensive activities of Pregabalin. The therapeutic efficacy of Procaine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Levomethadyl Acetate can be increased when used in combination with Pregabalin. The therapeutic efficacy of Fluticasone propionate can be increased when used in combination with Pregabalin. The therapeutic efficacy of Tetracaine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Dihydroetorphine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Levocabastine can be increased when used in combination with Pregabalin. The risk or severity of heart failure can be increased when Pregabalin is combined with Allicin. The therapeutic efficacy of Levodopa can be increased when used in combination with Pregabalin. The therapeutic efficacy of Oxazepam can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Pregabalin is combined with Desvenlafaxine. The therapeutic efficacy of Clemastine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Dyclonine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Imipramine can be increased when used in combination with Pregabalin. The therapeutic efficacy of Heroin can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Rufinamide is combined with Pregabalin. The therapeutic efficacy of Pregabalin can be decreased when used in combination with Calcium Phosphate. The risk or severity of adverse effects can be increased when Ketoconazole is combined with Pregabalin. Pregabalin may increase the sedative activities of Rotigotine. The therapeutic efficacy of Difenoxin can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Posaconazole is combined with Pregabalin. The therapeutic efficacy of Morphine can be increased when used in combination with Pregabalin. The risk or severity of adverse effects can be increased when Radicicol is combined with Pregabalin. The risk or severity of adverse effects can be increased when Nitroxoline is combined with Pregabalin. Nabilone may increase the central nervous system depressant (CNS depressant) activities of Pregabalin. The risk or severity of adverse effects can be increased when Pregabalin is combined with Nefazodone. The risk or severity of heart failure can be increased when Pregabalin is combined with Gusperimus.